Retailers, restaurants, apparel, packaged goods, household brands, and the consumer spending signals behind them.
In a move aimed at shoppers, Target is indicating more price cuts alongside an ongoing recovery effort, as momentum in revenue gives the retailer more room to compete on value.
THE APEX TIMES
THE APEX TIMES
In its latest quarter, Home Depot posted $47.9 billion in sales and $4.8 billion in net income, reaffirmed its fiscal 2026 outlook, and leaned on a mix of cash-return and policy-related cost offsets that investors will be watching for the second half.
THE APEX TIMES
After reporting second-quarter results, Home Depot and Lowe’s used their earnings messages to frame demand trends tied to housing and home improvement activity, according to market coverage this week.
THE APEX TIMES
The home-improvement retailer said its board has declared a quarterly cash dividend of $2.33 per share, with payment scheduled for mid-September 2026.
THE APEX TIMES
Nike stock slid to multi-year lows as the market questioned whether the company can quickly stabilize growth and sentiment. After shedding roughly $200 billion in value from late-2021 highs, the shares are looking cheaper, but not clearly “priced for perfection.”
THE APEX TIMES
A new partnership with SCAN Group will bring Costco-branded Medicare Advantage and supplement coverage to select states, extending the retailer’s health-care footprint beyond traditional pharmacy and membership benefits. Analysts are also asking how investors should think about the move’s financial significance.
THE APEX TIMES
After hitting the lowest level in about 12 years, Nike stock has recovered somewhat from the day’s lows, yet analysts are still looking for profits to drop again.
THE APEX TIMES
A new read on Walmart’s latest U.S. same-store sales has triggered renewed debate among investors about consumer demand and the risk that growth remains too weak to stabilize the outlook.
THE APEX TIMES
On Yahoo Finance, Jim Cramer told viewers he believes Target’s recovery is progressing, while still arguing investors should be patient rather than chasing the stock at current levels.
